BPC-157 Arginate vs OTR-AC — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
BPC-157 Arginate is the arginine salt form of BPC-157, identical in the GEPPPGKPADDAGLV peptide sequence but with improved water solubility, aqueous stability, and oral bioavailability. The arginate counterion buffers GI microenvironmental pH, reducing acid-catalyzed peptide degr...
Calculate BPC-157 Arginate dose →OTR-AC is the common name for oral high-dose BPC-157 acetate. The peptide sequence (GEPPPGKPADDAGLV) is identical to injectable BPC-157 but is dosed at 2–5 mg orally rather than 250–500 µg subcutaneously to compensate for GI degradation and first-pass metabolism. The oral route p...
Calculate OTR-AC dose →| Parameter | BPC-157 Arginate | OTR-AC |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| Research | Extensively Studied | Preclinical |
| Half-Life | 4–6 hours | 4–6 hours (estimated, oral) |
| Typical Dose | 250–500 µg | 2–5 mg |
| Frequency | Once or twice daily | Once daily |
| Route | Oral / Subcutaneous | Oral |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.